ArticleOncotarget2014

A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo.

Juan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.